Cartesian Therapeutics, Inc. (RNAC) stock
RNACNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.12+0.04 (+0.66%)
Close on Nov 17, 2026Market cap $185.16MP/E –Yield –
Cartesian Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Cartesian Therapeutics's price to book ratio was 1.8× on Jan 31, 2024, against 3.2× a year earlier. Over the last 5 years it ranged from 1.8× to 41.1×, with a median of 4.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Jan 31, 2024 | 1.8× | +0.1 |
| 2023 | Dec 29, 2023 | 1.8× | −0.3 |
| 2022 | Dec 30, 2022 | 2.0× | −25.7 |
| 2020 | Apr 30, 2020 | 27.8× | +22.3 |
| 2019 | Jul 31, 2019 | 5.4× | −2.6 |
| 2018 | Dec 31, 2018 | 8.0× | +4.7 |
| 2017 | Dec 29, 2017 | 3.3× | −1.4 |
| 2016 | Dec 30, 2016 | 4.8× | – |
See a number that looks wrong?